FDA Approves IV Artesunate for Severe Malaria

WEDNESDAY, May 27, 2020 -- Intravenous (IV) artesunate received approval from the U.S. Food and Drug Administration to treat adults and children with severe malaria, the agency announced Tuesday. This approval marks the first for severe malaria...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news